I totally hear you on this
@Kati but on a Facebook M.E forum there are people still arguing this 'As far as I know Lipkin found 85% in the Montoya patient samples. Mikovits and Lo/Alter found about 6% in the healthy controls and this is for sure one reason why it was not pursued.' I am still totally confused can you or anyone else explain? Many thanks
Lipkin found the same levels in patients and controls, which suggests he detected something other than a causal agent. (e.g. it could be contamination or cross reactivity.)
In the original study by Lo/Alter, different rates were detected in patients and controls which indicates a potentially significant finding and definitely something worth following up. Lo/Alter did follow up their research in the study that Lipkin supervised. Along with Mikovits, neither of them were able to replicate their original findings. (Some would say that it wasn't a true replication study, and that they weren't given a fair chance to replicate their original research.)
When people say that the low rate detected in the Lo/Alter healthy samples is the reason why the research was not followed up, I suspect that they are suggesting that the research was suppressed for political reasons. i.e. that the results suggest something very significant but the authorities don't want the public to know about a new retrovirus causing ME, so they've suppressed further research.
In my opinion, there was an obvious effort to shut down the XMRV media storm, and they used flawed research to justify their dismissal of XMRV. But if there was a new human retrovirus out there, I can't see how they could possibly keep a lid on it for long. Retrovirologists around the world would be itching to make a new discovery.